Few experiences in reproductive medicine are as difficult as the repeated loss of a pregnancy. For couples who have already begun to imagine a future with a child, each loss carries both a medical and a deeply personal weight. At New Hope IVF Hospital in Sharjah, we want patients to understand an important clinical fact: recurrent miscarriage is a recognised medical condition with identifiable causes in many cases, and it is often treatable. A structured evaluation frequently reveals a factor that can be corrected, managed, or bypassed with assisted reproductive technology.
What Is Recurrent Pregnancy Loss?
Recurrent pregnancy loss is generally defined as two or more consecutive clinical pregnancy losses before 20 weeks of gestation. It affects approximately one to two percent of couples trying to conceive. Importantly, a single miscarriage is common — occurring in roughly one in five recognised pregnancies — and does not usually indicate an underlying disorder. After two or three losses, however, a formal investigation is clinically justified and should not be delayed.
Genetic and Chromosomal Causes
Chromosomal abnormalities in the embryo are the single most frequent cause of early pregnancy loss, accounting for more than half of first-trimester miscarriages. Most of these arise sporadically during egg or sperm development and are not inherited. In a smaller subset of couples — around three to five percent — one partner carries a balanced chromosomal rearrangement, such as a balanced translocation. The carrier is healthy, but the embryos they produce may receive an unbalanced set of chromosomes, leading to repeated loss. Karyotype testing of both partners is therefore a standard part of the workup.
Uterine and Anatomical Factors
The structure of the uterus plays a decisive role in whether a pregnancy can implant and grow. Congenital anomalies such as a uterine septum, as well as acquired conditions including submucosal fibroids, endometrial polyps, and intrauterine adhesions (Asherman’s syndrome), can each interfere with implantation and placental development. These conditions are assessed with three-dimensional ultrasound, saline infusion sonography, or hysteroscopy. Many are correctable through minimally invasive hysteroscopic surgery, with measurable improvement in subsequent pregnancy outcomes.
Hormonal, Metabolic and Immunological Causes
Endocrine disorders are among the most modifiable contributors to recurrent loss. Uncontrolled thyroid disease, poorly managed diabetes, elevated prolactin, and insulin resistance associated with polycystic ovary syndrome all increase miscarriage risk, and all respond well to treatment. Vitamin D deficiency is also being increasingly recognised as a relevant factor in our region.
Antiphospholipid syndrome is the best-established immunological cause of recurrent miscarriage. This autoimmune clotting disorder is diagnosed through specific blood tests repeated at least twelve weeks apart, and it is treated effectively with low-dose aspirin combined with heparin during pregnancy. Inherited thrombophilias may also be evaluated in selected patients with a suggestive personal or family history.
How We Investigate Recurrent Miscarriage
A thorough evaluation at our centre typically includes a detailed medical and obstetric history, hormonal profiling including thyroid function and prolactin, screening for antiphospholipid antibodies, karyotype analysis of both partners, imaging of the uterine cavity, and assessment of sperm quality including DNA fragmentation where indicated. It is important for patients to know that even after a complete workup, no cause is identified in approximately half of couples. This is described as unexplained recurrent loss — and reassuringly, the live birth rate in this group remains favourable with supportive care.
Treatment and the Role of IVF
Treatment is directed at the cause identified. Surgical correction addresses anatomical factors; medication stabilises hormonal and thyroid disorders; anticoagulation manages antiphospholipid syndrome; and lifestyle modification — including smoking cessation, weight optimisation, and reduced caffeine intake — supports every treatment pathway.
Where a chromosomal rearrangement is present in a parent, or where losses continue despite optimisation, IVF combined with preimplantation genetic testing allows embryos to be screened for chromosomal balance before transfer. Selecting a chromosomally normal embryo can substantially reduce the risk of a further loss and shorten the time to a successful pregnancy.
Caring for the Whole Patient
The emotional burden of repeated loss is real and clinically significant. Structured supportive care — sometimes called tender loving care — including early pregnancy scans, frequent contact with the clinical team, and access to counselling, has been associated with improved outcomes. At New Hope IVF Hospital, we consider this support an integral part of treatment rather than an optional extra.
If you have experienced two or more pregnancy losses, we encourage you to arrange a consultation. A clear diagnosis is the first step toward a healthy pregnancy.